Similar Items: Multi-epitope mRNA vaccine and protein vaccine protect mice against
- Comparing COVID-19 vaccine effectiveness in Türkiye: heterologous, inactivated, and mRNA vaccines
- Interim Effectiveness of 2025–2026 mRNA-1283 and BNT162b2 COVID-19 Vaccines Against COVID-19-Related Outcomes Among Adults Aged ≥ 65 Years in the United States
- Gene-edited live-attenuated vaccines against : recent advances and future frontiers
- Antibodies Cross-Reactive with Bundibugyo Virus in Ferrets Vaccinated with Ebola Virus Vaccine
- Durability of RSV Antibodies After Vaccination in Immunosuppressed Persons
- Real-world Impact of HPV Vaccination on CIN2+ Reduction: A Meta-Analysis of Observational Studies Assessing Variation by Age, Coverage, and Vaccine Type